Search clinical trials for: Venoarterial Extracorporeal membrane oxygenation

Total 14361 results

Abbott

Terminated

Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness

Bipolar Disorder

United States
Abbott

Completed

Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium

Chronic Kidney Disease | Secondary Hyperparathyroidism

United States
Abbott

Terminated

Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on Hemodialysis

End-Stage Kidney Disease

United States
Portland VA Medical Center
GlaxoSmithKline; Schering-Plough

Completed

Antidepressant Prophylaxis for Interferon-Induced Depression: Efficacy of Paroxetine

Major Depression
Connolly, Stuart, M.D.
Abbott Medical Devices

Completed

Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC)

Ventricular Tachycardia

Canada
Abarbanel Mental Health Center

Completed

Tolerability and Efficacy of High Dose Escitalopram for the Treatment of Obsessive-Compulsive Disorder (OCD)

Obsessive-Compulsive Disorder

Israel
Eli Lilly and Company
Boehringer Ingelheim

Completed

Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.

Stress Urinary Incontinence

United States
Pfizer
PPD

Completed

A First In Human Study Of PF-00184562 In Healthy Volunteers

Schizophrenia

United States
Eli Lilly and Company

Completed

Duloxetine in the Treatment of Melancholic Depression

Depressive Disorder, Major

Australia, Canada
Eli Lilly and Company

Completed

Switching to Duloxetine From Other Antidepressants

Major Depressive Disorder

Spain, France, Ireland, United Kingdom
Eli Lilly and Company

Completed

Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed Episode

Bipolar Disorder

Spain
Eli Lilly and Company

Completed

Olanzapine in Patients With Borderline Personality Disorder

Borderline Personality Disorder

Germany, United States, Belgium, France, Norway, Portugal, Spain, Sweden, United Kingdom
Eli Lilly and Company

Completed

A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity Disorder

Attention Deficit Disorder With Hyperactivity

United States
Eli Lilly and Company

Completed

Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder

Borderline Personality Disorder

United States, Argentina, Poland, Romania, Turkey
Eli Lilly and Company

Completed

The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression

Major Depressive Disorder

United States, Canada
Pfizer

Completed

Pregabalin Open-Label Extension Trial in Patients With Partial Seizures

Epilepsies, Partial | Epilepsy, Complex Partial

Spain, France, Canada, Germany, Italy, Lithuania, Austria, United Kingdom
Eli Lilly and Company

Completed

A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia

Schizophrenia

United States
Eli Lilly and Company

Completed

Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia

Depression | Schizophrenia | Schizoaffective Disorder

United States
Eli Lilly and Company

Completed

Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain

Depression | Pain

United States
Eli Lilly and Company

Completed

Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia

Schizophrenia

United States, United Kingdom, Spain, Argentina, Mexico, Brazil, Peru, Puerto Rico, Germany, Austria, Ireland, Venezuela
Eli Lilly and Company

Completed

Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder

Depressive Disorder

United States
Eli Lilly and Company

Completed

Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression

Major Depressive Disorder

United States
Eli Lilly and Company

Completed

Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder

Bipolar Disorder

United States
Eli Lilly and Company

Completed

Pharmacokinetic Characterization of Intramuscular Olanzapine Depot

Schizophrenia | Schizoaffective Disorder

Australia, Belgium, Brazil, Croatia, Czech Republic, Mexico, Slovakia, Spain
Eli Lilly and Company

Completed

Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression

Major Depressive Disorder

United States
University of Toronto

Unknown

A Study of the Effect of Time on Topical Anesthetic Efficacy.

Pain

Canada
Pfizer

Completed

Determine Long-Term Safety and Tolerability of Pregabalin in Patients With Anxiety Disorders.

Anxiety Neuroses

Spain, Belgium, South Africa, Germany, United Kingdom, Poland, Austria, Estonia, France, Israel, Italy, Latvia, Netherlands, Ukraine
Advanced-J
Japan Heart Foundation

Unknown

A Study on Ca Blocker Versus AII Antagonists in Hypertension With Type 2 Diabetes

Hypertension | Diabetes Mellitus, Type 2

Japan
Rhode Island Hospital
Eli Lilly and Company

Unknown

Effect of Atomoxetine on ADHD-Related Insomnia in Children and Adolescents

Insomnia | Attention-Deficit/Hyperactivity Disorder (ADHD)

United States
Pennsylvania College of Optometry

Completed

A Randomized Trial of Base-in Prism Reading Glasses Convergence Insufficiency in Children

Convergence Insufficiency

United States
Singapore National Eye Centre
Singapore Eye Research Institute

Suspended

Transplantation of Cultivated Limbal Epithelium on Amniotic Membrane for Limbal Stem Cell Deficiency

Ocular Surface Disease
University of Arizona

Completed

Bupropion Treatment for Youth Smoking Cessation

Nicotine Dependence

United States
Michael E. DeBakey VA Medical Center
Dr. Thomas A. Kent; Dr. Stacey Holmes; Dr. Su Bailey; Dr. Mark Kunik; Dr. Melinda...

Unknown

Pilot Trial of Neural Correlates of Response to Treatment of PTSD-Associated Impulsive Aggression

Posttraumatic Stress Disorder | Impulsive Aggression

United States
Novacea

Unknown

Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004

Non Small Cell Lung Cancer (NSCLC) | Androgen Independent Prostate Cancer (AIPC)

Canada, United States
Taoyuan Psychiatric Center, Ministry of Health...
Department of Health

Completed

Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism

Schizophrenia | Extrapyramidal Syndrome

Taiwan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder

Social Anxiety Disorder
Centre of Chinese Medicine, Georgia
Rea Rehabilitation Centre, Georgia

Completed

Antiepileptic Drug Carbamazepine in Treatment of Bronchial Asthma

Bronchial Asthma
OSF Healthcare System
PDL BioPharma, Inc.

Unknown

IV Double and Triple Concentrated Nicardipine for Stroke and ICH

Hypertension

United States
Chinese University of Hong Kong
New World Development Company Limited

Completed

Treatment of Tennis Elbow With Botulinum Toxin

Epicondylitis, Lateral Humeral

Hong Kong
University of Calgary
Wyeth is now a wholly owned subsidiary of Pfizer; Heart and Stroke Foundation...

Completed

Amiodarone to Prevent Post-Operative Arrhythmias

Atrial Fibrillation

Canada
Shiga University

Unknown

Rationale and Design for Shiga Microalbuminuria Reduction Trial

Hypertension | Diabetes Mellitus | Albuminuria

Japan
Steno Diabetes Center Copenhagen
Bayer

Completed

Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic Nephropathy

Diabetic Nephropathy

Denmark
Assistance Publique - Hôpitaux de Paris

Unknown

Local Anesthesia and Tuberculin Skin Test in Infants and Children

Tuberculosis

France
Utrecht Institute for Pharmaceutical Sciences

Completed

Methylphenidate and Driving Ability in Adult Patients With Attention-Deficit Hyperactivity Disorder

ADHD

Netherlands
Tripler Army Medical Center

Unknown

Safety Study of Membrane Sweeping in Pregnancy

Pregnancy | Prelabor Rupture of Membranes

United States
University of Aarhus

Completed

Reduction of Atrial Fibrillation Study in Patients Undergoing Coronary Artery Bypass Grafting. (RASCABG 1 Study)

Atrial Fibrillation | Coronary Artery Bypass Grafting

Denmark
Brown University

Unknown

Comparison of Alcohol and Steroid Injection for Treating Morton's Neuroma

Morton's Neuroma

United States
University of North Carolina
Cystic Fibrosis Foundation

Completed

Efficacy of Amiloride and Hypertonic Saline in Cystic Fibrosis

Cystic Fibrosis

United States
Medical University of Vienna

Unknown

Treatment of Chronic GVHD of Liver or Lungs by ECP

Chronic Graft-Versus Host Disease

Austria
The University of New South Wales

Completed

Escitalopram as a Mood Stabilizer for Bipolar II Disorder

Bipolar Disorders

Australia

Search clinical trials for: Venoarterial Extracorporeal membrane oxygenation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations